| [1] |
Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat Med,1997,3:730-737.
|
| [2] |
Glinsky GV,Berezovska O,Glinskii AB.Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.J Clin Invest,2005,115:1503-1521.
|
| [3] |
Spillane JB,Henderson MA.Cancer stem cells:a review.ANZ JSurg,2007,77:464-468.
|
| [4] |
Dean M,Fojo T,Bates S.Tumour stem cells and drug resistance.Nat Rev Cancer,2005,5:275-284.
|
| [5] |
Potten CS,Loeffler M.Stem cells:attributes,cycles,spirals,pitfalls and uncertainties.Lessons for and from the crypt.Development 1990,110:1001-1020.
|
| [6] |
Al Hajj M,Wicha MS,Benito Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA,2003,100:3983-3988.
|
| [7] |
Shackleton M,Vaillant F,Simpson KJ,et al.Generation of a functional mammary gland from a single stem cell.Nature,2006,439:84-88.
|
| [8] |
Hwang Verslues WW,Chang KJ,Lee HP,et al.Breast cancer stem cells and tumor suppressor genes.J Formos Med Assoc,2008,107:751-766.
|
| [9] |
Zhou S,Schuetz JD,Bunting KD,et al.The ABC transporter crp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.Nat Med,2001,7:1028-1034.
|
| [10] |
Donnenberg VS,Landreneau RJ,Donnenberg RD.Tumorigenic stem and progenitor cells:implications for the therapeutic index of anti-cancer agents.J Control Release,2007,122:385-391.
|
| [11] |
Haraguchi N,Utsunomiya T,Inoue H,et al.Characterization of a side population of cancer cells from human gastrointestinal system.Stem Cells,2006,24:506-513.
|
| [12] |
Wang J,Guo LP,Chen LZ,et al.Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.Cancer Res,2007,67:3716-3724.
|
| [13] |
Alvi AJ,Clayton H,Joshi C,et a1.Functional and molecular characterization of mammary side population cells.Breast Cancer Res,2003,5:R1-R8.
|
| [14] |
Xu JX,Morii E,Liu YL,et al.High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells:high expression of CD55 as a novel character for side-population.Exp Cell Res,2007,313:1877-1885.
|
| [15] |
Wright MH,Calcagno AM,Salcido CD,et al.Brca1 breast tumors contain distinct CD44+/CD24-and CD133+cells with cancer stem cell characteristics.Breast Cancer Res,2008,10:R10.
|
| [16] |
Ginestier C,Hur MH,Charafe Jauffret E,et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell,2007,1:555-567.
|
| [17] |
Shipitsin M,Campbell LL,Argani P,et al.Molecular definition of breast tumor heterogeneity.Cancer Cell,2007,11:259-273.
|
| [18] |
Zhou ZH,Ping YF,Yu SC,et al.A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line.Cancer Letters,2009,281:92-99.
|
| [19] |
Ponti D,Costa A,Zaffaroni N,et al.Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.Cancer Res,2005,65:5506-5511.
|
| [20] |
Barrandon Y,Green H.Three clonal types of keratinocyte with different capacities for multiplication.Proc Natl Acad Sci USA,1987,84:2302-2306.
|
| [21] |
谢竞,周艳,唐鹏,等.克隆柱法提取MCF-7乳腺癌细胞系中癌干细胞.中华乳腺病杂志:电子版,2009,3:187-194.
|
| [22] |
Chuthapisith S,Eremin J,El Sheemey M,et al.Breast cancer chemoresistance:emerging importance of cancer stem cells.Surg Oncol,2010,19:27-32.
|
| [23] |
Cairns J.Cancer and the immortal strand hypothesis.Genetics,2006,174:1069-1072.
|
| [24] |
Chang JC,Wooten EC,Tsimelzon A,et a1.Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.J Clin Oncol,2005,23:1169-1177.
|
| [25] |
Hirschmann Jax C,Foster AE,Wulf GG,et al.A distinct＂side population＂of cells with high drug efflux capacity in human tumor cells.Proc Natl Acad Sci USA,2004,101:14228-14233.
|
| [26] |
Dean M,Fojo T,Bates S.Tumour stem cells and drug resistance.Nat Rev Cancer,2005,5:275-284.
|
| [27] |
Steiniger SCJ,Coppinger JA,Kruger JA,et a1.Quantitative mass spectrometry identifies drug targets in cancer stem cellcontaining side population.Stem Cells,2008,26:3037-3046.
|
| [28] |
Dylla SJ,Beviglia L,Park IK,et al.Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.PLoS One,2008,3:e2428.
|
| [29] |
Bao F,Polk P,Nordberg ML,et al.Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors.Leuk Res,2007,31:1511-1520.
|
| [30] |
Phillips TM,McBride WH,Pajonk F.The response of CD24(-/low)/CD44+breast cancer-initiating cells to radiation.J Natl Cancer Inst,2006,98:1777-1785.
|
| [31] |
Li X,Lewis MT,Huang J,et al.Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.J Natl Cancer Inst,2008,100:672-679.
|
| [32] |
Massard C,Deutsch E,Soria JC.Tumour stem cell-targeted treatment:elimination or differentiation.Ann Oncol,2006,17:1620-1624.
|
| [33] |
Pardal R,Clarke MF,Morrison SJ.Applying the principles of stem-cell biology to cancer.Nat Rev Cancer,2003,3:895-902.
|
| [34] |
Dave B,Chang J.Treatment Resistance in Stem Cells and Breast Cancer.J Mammary Gland Biol Neoplasia,2009,14:79-82.
|
| [35] |
Yang CH,Huang CJ,Yang CS,et al.Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.Cancer Res,2005,65:6943-6949.
|
| [36] |
Takigawa N,Takeyama M,Kozuki T,et al.Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells.Oncol Rep,2007,17:983-987.
|
| [37] |
Erfurt C,Emmerling S,Klotz C,et al.Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients.Int J Cancer,2009,124:2341-2346.
|
| [38] |
Gupta AK,Ferry A,Amoozgar M,et al.A monoclonal antibody targeting the breast cancer stem cell marker melanoma-associated chondroitin sulfate proteoglycan improves survival and demonstrates anti-tumor activity in vivo.EJC Supplements,2008,6:165-165.
|
| [39] |
Ribacka C,Pesonen S,Hemminki A.Cancer,stem cells,and oncolytic viruses.Ann Med,2008,40:496-505.
|
| [40] |
Ohno R,Asou N,Ohnishi K.Treatment of acute promyelocytic leukemia:strategy toward further increase of cure rate.Leukemia,2003,17:1454-1463.
|
| [41] |
Piccirillo SG,Reynolds BA,Zanetti N,et al.Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.Nature,2006,444:761-765.
|
| [42] |
Huntly BJ,Gilliland DG.Leukaemia stem cells and the evolution of cancer-stem-cell research.Nature Rev Cancer,2005,5:311-321.
|
| [43] |
Baguley BC.Tumor stem cell niches:a new functional framework for the action of anticancer drugs.Recent Pat Anticancer Drug Discov,2006,1:121-127.
|